significant drug interaction

clinically significant interaction between two pharmacologically active substances (i.e., drugs and/or active metabolites) where concomitant intake can lead to altered effectiveness or adverse drug events.

Wikidata entity: P769



P31 instance of ... Q119301849 (Wikidata property related to method, methodology or mode of actions) Wikidata property related to method, methodology or mode of actions
P31 instance of ... Q19887775 (Wikidata property related to medicine) Wikidata property related to medicine
P2302 property constraint ... Q21503250 (subject type constraint) subject type constraint
P2302 property constraint ... Q21503247 (item-requires-statement constraint) item-requires-statement constraint
P2302 property constraint ... Q21510864 (value-requires-statement constraint) value-requires-statement constraint
P2302 property constraint ... Q21510865 (value-type constraint) value-type constraint
P2302 property constraint ... Q53869507 (property scope constraint) property scope constraint
P3254 property proposal discussion Url Wikidata:Property proposal/Archive/12 - Wikidata ???
P2875 property usage tracking category ... Q26249998 (Category:Pages using Wikidata property P769) Category:Pages using Wikidata property P769
P1896 source website for the property Url None ???
P1629 Wikidata item of this property ... Q718753 (drug interaction) drug interaction
P1855 Wikidata property example ... Q407431 ((RS)-warfarin) (RS)-warfarin
P1855 Wikidata property example ... Q416978 (sumatriptan) sumatriptan

Why not click here or view trends?

log id: 2877500